N8 Medical News – N8 Medical

NIH Awards N8 Medical Two Additional SBIR Grants to Develop CeraShieldTM Coated Hemodialysis Catheters and Pedicle Screws

(more…)

January 6, 2023

N8 Medical Is Awarded Almost $2 Million in Phase II SBIR Grant

(more…)

July 5, 2022

N8 Medical Announces its CeraShield™ Coating inhibits COVID-19 Virus Growth on Endotracheal Tubes

(more…)

August 11, 2020

Health Canada Grants Emergency Use Authorization for N8 Medical CeraShield™ Endotracheal Tubes in Mechanically Ventilated COVID-19 Patients

(more…)

April 2, 2020

Frost & Sullivan awards N8 Medical New Product Innovation Award for its Platform Medical Device Technology to Prevent Hospital-Acquired Infections

(more…)

November 7, 2019

N8 Medical Appoints Infectious Diseases Expert, David S. Perlin, Ph.D., to Scientific Advisory Board

(more…)

November 8, 2018

N8 Medical Announces NHLBI Grant to Develop Antimicrobial Pacemaker Envelope

CeraShield™ resorbable envelope targets prevention of bacterial and highly lethal fungal infections and reduction of surgical site infections of pacemaker implantations

(more…)

August 7, 2018

Published Research Shows CSA-131’s Potent Efficacy against Global Health Threat

New Publication regarding Ceragenin CSA-131’s Potent Efficacy against fungal pathogen Candida auris, a New Serious Global Health Threat

(more…)

April 5, 2018

N8 Medical Announces Compelling Publication Supporting Its Breakthrough CeraShield™ Endotracheal Tube

CeraShield™ Coating Prevents Bacterial and Fungal Colonization, and Reduces Endotoxin

(more…)

November 3, 2017

FDA Grants N8 Medical Breakthrough Device Designation

FDA Grants N8 Medical’s Request for Breakthrough Device Designation for its CeraShield™ Endotracheal Tube

(more…)

May 17, 2017

Category: N8 Medical News